Platelet PD-L1 reflects collective intratumoral PD-L1 expression and predicts immunotherapy response in non-small cell lung cancer - Hinterleitner, Clemens; Strähle, Jasmin; Malenke, Elke; Hinterleitner, Martina; Henning, Melanie; Seehawer, Marco; Bilich, Tatjana; Heitmann, Jonas; Lutz, Martina; Mattern, Sven; Scheuermann, Sophia; Horger, Marius; et al. (Nature communications, 2021)
Keywords: 13/1; 13/109; 13/31; 13/51; 14/19; 14/63; 631/67/1612/1350; 631/67/1857; 631/67/580; 82/51; Adult; Aged; Aged, 80 and over; Algorithms; B7-H1 Antigen - genetics; B7-H1 Antigen - metabolism; Biomarkers; Biomarkers, Tumor; Biopsy; Blood platelets; Blood Platelets - metabolism; Carcinoma, Non-Small-Cell Lung - immunology; Carcinoma, Non-Small-Cell Lung - pathology; Carcinoma, Non-Small-Cell Lung - therapy; CD4 antigen; CD8 antigen; Female; Fibronectin; Humanities and Social Sciences; Humans; Immune checkpoint inhibitors; Immunologic Factors; Immunotherapy; Inhibitors; L1 protein; Lung cancer; Lung Neoplasms - immunology; Lung Neoplasms - pathology; Lung Neoplasms - therapy; Lymphocytes T; Male; Middle Aged; multidisciplinary; Non-small cell lung carcinoma; Patients; PD-L1 protein; Platelets; Science; Science (multidisciplinary); Small cell lung carcinoma; T-Lymphocytes; Therapy; Tumor cells; Tumors; Young Adult